GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Basedz Therapies in Treating Metabolic Disorders

During the past decade, pharmaceutical engineering of unimolecular agents has revealed the therapeutic potential of glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism. From this work, one of the most intriguing findings is that engagement of GIPR enhances the weight loss profile of...

Descripción completa

Detalles Bibliográficos
Autores principales: Samms, Ricardo J., Sloop, Kyle W., Gribble, Fiona M., Reimann, Frank, Adriaenssens, Alice E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2021
Materias:
Diabetes Symposium
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576420/
https://www.ncbi.nlm.nih.gov/pubmed/34176786
http://dx.doi.org/10.2337/dbi21-0002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576420/
https://www.ncbi.nlm.nih.gov/pubmed/34176786
http://dx.doi.org/10.2337/dbi21-0002

Ejemplares similares